Epilepsy is a chronic neurological disorder marked by recurrent seizures caused by abnormal electrical activity in the brain. It affects over 50 million people globally and encompasses diverse syndromes ranging from focal to generalized types. Understanding the underlying neurophysiology, genetics, and molecular signaling in epilepsy remains central to developing better diagnostics and therapies.

The Epilepsy session addresses breakthroughs in seizure pathogenesis, neuroimaging, and treatment innovations. Researchers investigate how ion-channel mutations, neurotransmitter imbalances, and cortical-network dysregulation contribute to epileptogenesis. Studies also explore how inflammation, trauma, and metabolic dysfunction trigger recurrent seizures.

At the Epilepsy Conference, scientists and clinicians present updates on surgical procedures, antiepileptic drugs, and non-invasive interventions such as vagus-nerve stimulation and transcranial stimulation. Precision-medicine approaches are revolutionizing care by tailoring treatments to genetic and metabolic profiles.

This session is invaluable for neurologists, epileptologists, and neuroscientists aiming to bridge basic research with clinical care. Topics include seizure prediction algorithms, AI-based EEG analysis, and lifestyle management strategies improving long-term outcomes.

Recent findings from Neurodiagnostics Innovation continue to shape understanding of seizure networks, leading to more accurate diagnosis and seizure-free living for many patients.